7H: Biomaterials for In Vitro Models of Disease 2
Time: 8:00 AM to 10:00 AM
Description
This session is dedicated to biomaterials used in the fabrication of in vitro disease models and will highlight cutting-edge strategies for replicating pathological conditions outside the human body. Topics will include the use of biomaterials in the development of organoids, microphysiological systems, and hydrogels for 3D cell culture. The session will explore their applications in studying disease mechanisms, drug testing, and recent advancements in leveraging these platforms for personalized medicine and therapeutic development.
Moderators:
Silviya Zustiak, Ph.D
Professor and Associate Chair; Co-Director, Institute of Drug and Biotherapeutic Innovation at SLU
Biomedical Engineering
Professor of Pharmacology and Physiology
Saint Louis University
Kyle Lampe
Associate Professor, Chemical EngineeringAssociate Professor, Biomedical Engineering and Neuroscience
The University of Virginia
8:00 AM. 396. Talk by Melissa Kemp, Georgia Institute of Technology
9:15 AM. 400. Comparative Transcriptomic Analysis of a 3D PEG-based Lung Tumor Model to Subcutaneous Xenograft.Suzanne Lightsey1, Heather Kates, PhD1, Kalyanee Shirlekar, PhD1, Jason Brant, PhD1, Blanka Sharma, PhD1 1University of Florida
9:30 AM. 401. Compressive Bioreactor Enables Evaluation of Anti-Inflammatory Drug Responses in Young and Aged Donor-Derived Mesenchymal Stromal Cells.Thai Thanh Hoang1, Katherine Griffin1, Sabrina Mierswa1, J. Kent Leach1 1UC Davis Health
9:45 AM. 402. Engineering Focal Cardiac Fibrosis Models via Digital Light Processing of Hydrogel Molds.Jason Burdick, Ph.D.1, Mackenzie Obenreder, B.S. Biomedical Engineering, Boston University1, Arianna McCarty1 1University of Colorado Boulder